Maximum quantity allowed is 999
Please select the quantity
CAS RN: 160807-49-8 | Product Number: I1118
Indirubin-3'-monoxime
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- 3-(Hydroxyimino)[2,3'-biindolinylidene]-2'-one
- 3-[1,3-Dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-2H-indol-2-one
- Indirubin-3'-oxime
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 50MG |
$300.00
|
0 | 32 | Contact Us |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | I1118 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__6H__1__1N__3O__2 = 277.28 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Frozen (-20°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Light Sensitive,Air Sensitive,Heat Sensitive |
| CAS RN | 160807-49-8 |
| Reaxys Registry Number | 10094715 |
Specifications
| Appearance | Light yellow to Brown powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Melting point | 239.0 to 243.0 °C |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 241 °C |
GHS
Related Laws:
Transport Information:
| H.S.code* | 2933.79-000 |
Application
Indirubin-3'-monoxime: A Non-Specific Protein Kinase Inhibitor
Indirubin [I0868] is an active constituent of the traditional Chinese Medicine Danggui Longhui Wan which is used for years in the treatment of chronic myelocytic leukemia.1) Indirubin-3'-monoxime is a cell permeable derivative of indirubin, and a potent inhibitor of cyclin-dependent kinases (CDK) and glycogen synthase kinase-3β (GSK3β).1,2) There are reports that indirubin-3'-monoxime induce apoptosis and tumor cell death in transitional cell cancer cell lines.3) Indirubin-3'-monoxime also inhibits LRRK2 (leucine-rich repeat kinase 2) that is a promising therapeutic target for the treatment of Parkinson's disease.4,5) (The product is for research purpose only.)
References
- 1) Indirubin, the active constituent of a Chinese antileukemia medicine, inhibits cyclin-dependent kinases
- 2) GSK-3-Selective Inhibitors Derived from Tyrian Purple Indirubins
- 3) Antiproliferative and apoptosis inducing effects of indirubin-3'-monoxime in renal cell cancer cells
- 4) Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
- 5) Development of LRRK2 Inhibitors for the Treatment of Parkinson’s Disease (a review)
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.